# A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy

> **NCT05582395** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 580 (actual)

## Conditions studied

- Cardiomyopathy, Hypertrophic

## Interventions

- **DRUG:** Mavacamten
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05582395
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-14
- **Primary completion:** 2025-03-06
- **Final completion:** 2025-10-20
- **Target enrollment:** 580 (ACTUAL)
- **Last updated:** 2025-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05582395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05582395, "A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05582395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*